Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Colgate-Palmolive Co (NYSE: CL) closed at $79.69 in the last session, down -0.05% from day before closing price of $79.73. In other words, the price has decreased by -$0.05 from its previous closing price. On the day, 3.24 million shares were traded. CL stock price reached its highest trading level at $80.095 during the session, while it also had its lowest trading level at $79.44.
Ratios:
We take a closer look at CL’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 43.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.66. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 0.93. In the meantime, Its Debt-to-Equity ratio is 9.84 whereas as Long-Term Debt/Eq ratio is at 8.54.
On December 09, 2025, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform but kept the price unchanged to $88.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 21 ’25 when Massey Sally sold 1,237 shares for $80.89 per share. The transaction valued at 100,061 led to the insider holds 13,751 shares of the business.
Massey Sally sold 2,250 shares of CL for $200,183 on May 15 ’25. The Chief Human Resources Officer now owns 12,583 shares after completing the transaction at $88.97 per share. On Feb 25 ’25, another insider, Massey Sally, who serves as the Chief Human Resources Officer of the company, sold 8,000 shares for $92.02 each. As a result, the insider received 736,152 and left with 14,805 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CL now has a Market Capitalization of 64407117824 and an Enterprise Value of 71564312576. As of this moment, Colgate-Palmolive’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.33, and their Forward P/E ratio for the next fiscal year is 20.79. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.20 while its Price-to-Book (P/B) ratio in mrq is 75.04. Its current Enterprise Value per Revenue stands at 3.561 whereas that against EBITDA is 14.872.
Stock Price History:
The Beta on a monthly basis for CL is 0.30, which has changed by -0.12297875 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, CL has reached a high of $100.18, while it has fallen to a 52-week low of $74.54. The 50-Day Moving Average of the stock is 1.58%, while the 200-Day Moving Average is calculated to be -6.64%.
Shares Statistics:
According to the various share statistics, CL traded on average about 6.58M shares per day over the past 3-months and 5763330 shares per day over the past 10 days. A total of 806.06M shares are outstanding, with a floating share count of 804.88M. Insiders hold about 0.15% of the company’s shares, while institutions hold 86.03% stake in the company. Shares short for CL as of 1765756800 were 13516071 with a Short Ratio of 2.05, compared to 1763078400 on 14262439. Therefore, it implies a Short% of Shares Outstanding of 13516071 and a Short% of Float of 1.87.
Dividends & Splits
The forward annual dividend rate for CL is 2.06, which was 2.04 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.025586352. The stock’s 5-year Average Dividend Yield is 2.3. The current Payout Ratio is 56.42% for CL, which recently paid a dividend on 2025-10-17 with an ex-dividend date of 2026-01-21. Stock splits for the company last occurred on 2013-05-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
Colgate-Palmolive Co (CL) is presently subject to a detailed evaluation by 16.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.94, with high estimates of $1.0 and low estimates of $0.9.
Analysts are recommending an EPS of between $3.69 and $3.61 for the fiscal current year, implying an average EPS of $3.66. EPS for the following year is $3.84, with 19.0 analysts recommending between $3.97 and $3.75.
Revenue Estimates
According to 12 analysts,. The current quarter’s revenue is expected to be $5.13B. It ranges from a high estimate of $5.23B to a low estimate of $5.02B. As of. The current estimate, Colgate-Palmolive Co’s year-ago sales were $4.94BFor the next quarter, 12 analysts are estimating revenue of $5.15B. There is a high estimate of $5.24B for the next quarter, whereas the lowest estimate is $5B.
A total of 18 analysts have provided revenue estimates for CL’s current fiscal year. The highest revenue estimate was $20.43B, while the lowest revenue estimate was $19.98B, resulting in an average revenue estimate of $20.28B. In the same quarter a year ago, actual revenue was $20.1BBased on 18 analysts’ estimates, the company’s revenue will be $20.97B in the next fiscal year. The high estimate is $21.28B and the low estimate is $20.61B.
